Literature DB >> 97359

Control of immunoglobulin secretion in the murine plasmacytoma line MOPC 315.

G E Sonenshein, M Siekevitz, G R Siebert, M L Gefter.   

Abstract

Cells of the 315LV-1 (derived from NP1) variant line of MOPC 315 contain approximately 1% the normal intracellular level of the heavy (alpha) chain of IgA and no detectable light (lambda2) chain. The synthesis rate of alpha-chain in the variant, however, is similar to that in cells of the parent line. Moreover the relative amount of translatable alpha-chain mRNA that can be extracted from 315LV-1 cells is about the same as for parental cells. No light-chain synthesis can be detected either in vivo or in vitro in a wheat germ cell-free system. The 315LV-1 heavy chain synthesized in vivo or in vitro has slightly greater electrophoretic mobility than normal H chain and turns over rapidly intracellularly. The variant fails to secrete any of its heavy chain, despite the fact that its H chain mRNA is bound to membranes, as one would expect for a secretory protein message. Fusion of 315LV-1 cells with cells of a kappa-producing MPC 11 variant line leads to stabilization of the intracellular H chain and also to full recovery of secretion of the H chain as an H2L2 molecule.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 97359      PMCID: PMC2184924          DOI: 10.1084/jem.148.1.301

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  28 in total

1.  Amino acid sequence of the precursor region of MOPC-315 mouse immunoglobulin heavy chain.

Authors:  R L Jilka; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

2.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

3.  Heavy chain-producing variants of a mouse myeloma cell line.

Authors:  S L Morrison; M D Scharff
Journal:  J Immunol       Date:  1975-02       Impact factor: 5.422

4.  Structure and function of the J chain.

Authors:  M E Koshland
Journal:  Adv Immunol       Date:  1975       Impact factor: 3.543

5.  Amino acid sequence of the NH2-terminal extra piece segments of the precursors of mouse immunoglobulin lambda1-type and kappa-type light chains.

Authors:  Y Burstein; I Schechter
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

6.  Studies of the mechanism of tunicamycin in hibition of IgA and IgE secretion by plasma cells.

Authors:  S Hickman; A Kulczycki; R G Lynch; S Kornfeld
Journal:  J Biol Chem       Date:  1977-06-25       Impact factor: 5.157

7.  Somatic cell hybridization of mouse myeloma cells.

Authors:  D H Margulies; W M Kuehl; M D Scharff
Journal:  Cell       Date:  1976-07       Impact factor: 41.582

8.  Synthesis but not secretion of J chain by variant mouse myeloma cells which lose alpha-chain-synthesizing ability.

Authors:  T Mosmann; R Baumal
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

9.  A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells.

Authors:  M L Gefter; D H Margulies; M D Scharff
Journal:  Somatic Cell Genet       Date:  1977-03

10.  Transfer of proteins across membranes. I. Presence of proteolytically processed and unprocessed nascent immunoglobulin light chains on membrane-bound ribosomes of murine myeloma.

Authors:  G Blobel; B Dobberstein
Journal:  J Cell Biol       Date:  1975-12       Impact factor: 10.539

View more
  10 in total

1.  A single amino acid substitution in the variable region of the light chain specifically blocks immunoglobulin secretion.

Authors:  J L Dul; Y Argon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-10       Impact factor: 11.205

Review 2.  Mutations that influence the secretory path in animal cells.

Authors:  A M Tartakoff
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

3.  Immunoglobulin heavy chain toxicity in plasma cells is neutralized by fusion to pre-B cells.

Authors:  I G Haas; M R Wabl
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

4.  Mutations affecting the structure and function of immunoglobulin M.

Authors:  M J Shulman; C Heusser; C Filkin; G Köhler
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

5.  Isolation of cDNAs encoding a human protein that binds selectively to DNA modified by the anticancer drug cis-diamminedichloroplatinum(II)

Authors:  J H Toney; B A Donahue; P J Kellett; S L Bruhn; J M Essigmann; S J Lippard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

6.  Roles of heavy and light chains in IgM polymerization.

Authors:  K D Bornemann; J W Brewer; G B Beck-Engeser; R B Corley; I G Haas; H M Jäck
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-23       Impact factor: 11.205

7.  Defective secretion of an immunoglobulin caused by mutations in the heavy chain complementarity determining region 2.

Authors:  C Chen; T M Martin; S Stevens; M B Rittenberg
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

8.  Surrogate or conventional light chains are required for membrane immunoglobulin mu to activate the precursor B cell transition.

Authors:  F Papavasiliou; M Jankovic; M C Nussenzweig
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

9.  Production of Autoreactive Heavy Chain-Only Antibodies in Systemic Lupus Erythematosus.

Authors:  Shu Xu; Hong Yang; Yue Zhuo; Yangsheng Yu; Hongyan Liao; Song Li; Yinshi Yue; Kaihong Su; Zhixin Zhang
Journal:  Front Immunol       Date:  2020-05-05       Impact factor: 7.561

10.  T lymphocyte-mediated suppression of myeloma function in vitro. III. Regulation of antibody production in hybrid myeloma cells by T lymphocytes.

Authors:  A K Abbas; S J Burakoff; M L Gefter; M I Greene
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.